If keeping up with the volume of safety letters you need to distribute to investigators during clinical trials is becoming more of a struggle, then you’re not alone. That’s because global safety regulations have grown exponentially over the past two decades. At the same time, trials have grown more complex by every measure.
With no sign of these trends reversing, your current use of manual trackers along with email or even various postal and parcel carrier systems to distribute safety notifications is unsustainable and may lead to compliance risks. You need a solution that can scale with the growing matrix of trials, investigators, countries, molecules, safety report types, and distribution rules.